BHIVA BASSH joint conference 2026: New modelling estimates scale of PrEP expansion needed to support England’s HIV elimination ambitions
Aquarius Population Health presented new modelling research at the BHIVA BASSH joint conference 2026, 27th -29th April, estimating the additional number of people that may need to receive PrEP between 2026 and 2030 to help England meet its 2030 HIV transmission elimination goal. England has committed to ambitious HIV transmission elimination targets by 20301. Although Read More >
EU27 not on track to end HIV transmission by 2030, new modelling shows
Updated modelling suggests around 242,000 new infections could occur across the EU27 by 2030 without increased prevention efforts. Read More >
Tales from opposite corners of the world: Emergency department opt-out testing: A cost-effective route to earlier HIV and Hepatitis diagnosis in Australia and Germany
Emergency department opt-out testing: A cost-effective route to earlier HIV and Hepatitis diagnosis in Australia and Germany.
Australia and Germany have both made progress toward HIV and viral hepatitis elimination targets, yet a significant share of infections remains undiagnosed.
• HBV: 31% undiagnosed in Australia (3); 80% in Germany (4)
• HCV: 16% undiagnosed in Australia (5); 63% in Germany (6)
• HIV: around 8% undiagnosed in both countries (7,8)
These levels of undiagnosed infection indicate that standard blood-borne virus (BBV) testing approaches are not sufficient to meet public health goals.
Read More >
When will the UK achieve HIV transmission elimination? Modelling the impact of current HIV prevention efforts on progress towards the 2030 elimination goal
In 2019, the previous UK government set the ambitious target of eliminating HIV transmission within the UK by 2030. While great progress has been made in HIV prevention and treatment in the UK, with England reaching the UNAIDS 95-95-95 target in 20231, past evidence suggested that the goal of ‘elimination’ by 2030 is unlikely to Read More >
User experience and workflow performance: a pilot evaluation of the Genius Digital Diagnostics System for screening cervical cytology samples
It is generally understood that the cytology work process can be stressful and fatiguing affecting technicians’ performance and job satisfaction on a day-to-day basis and in the longer term. This study assessed the performance and user experience of cytotechnologists (CTs) reviewing liquid-based cytology samples using a new digital cytology platform Genius Digital Diagnostics System (Genius Read More >
Research in Dravet syndrome and cervical cancer screening presented at international conferences
Aquarius has recently presented posters at international conferences (ISPOR, a conference for the leading professional society for health economics and outcomes research and EUROGIN, an international multidisciplinary HPV conference), exploring the impact of improving healthcare for two very different conditions: Dravet syndrome (rare debilitating epilepsy) and cervical cancer. Read More >
Could a same day test and treatment service in further education colleges improve uptake of chlamydia testing among young people?
Aquarius were part of a recent feasibility trial looking at whether provision of a same day test and treatment service for chlamydia in further education colleges increased uptake of chlamydia testing and treatment. The results of the trial were published this week in Clinical Microbiology and Infection and are available online. Read More >
Assessing the impact of point-of-care testing for influenza and RSV in children admitted to hospital
The winter flu season brings added pressure to emergency and acute hospital services. In the UK, children and infants account for more than a third of flu related hospital admissions since flu and respiratory syncytial viruses (RSV) can be particularly severe in children, particularly those with existing conditions such as asthma. In our recent paper Read More >
PRESS RELEASE: Aquarius Population Health wins a prestigious SBRI grant from Innovate UK
Work has begun to develop a digital value proposition tool for a novel rapid sexually transmitted infection (STI) test London, UK, 14 August 2017 Aquarius Population Health, a leading independent health economics consultancy, has recently been awarded an 18-month Innovate UK grant in collaboration with Atlas Genetics Ltd and the Applied Diagnostic Research and Evaluation Read More >
Evaluating the use AMR POCT in treatment of gonorrhoea
Aquarius Population Health recently worked with the Applied Diagnostic Research & Evaluation Unit (ADREU) at St. Georges, University of London, to assess the cost-effectiveness of six hypothetical strategies for using antimicrobial resistance point-of-care testing to guide the treatment of gonorrhoea. Our findings were presented at the STI & HIV World Congress in Rio de Janeiro, Read More >